Siguru AI has raised $3.0M to bring its AI-powered review tooling to more pharmaceutical commercial and medical teams.
The company sells software that speeds up medical, legal, and regulatory (MLR) review - the compliance gauntlet every pharma marketing and medical asset has to clear before it goes out. Siguru says its tool cuts review time by 14x, integrates with existing systems like Veeva, and includes a social media safeguarding feature it describes as the first of its kind. Brand and medical teams use it to catch compliance issues before submission rather than after.














